Back to today’s briefing

Story perspectives

Kaiser Permanente Appoints AI VP Amid FDA Guidelines

1/8/2025

23 1

Summary

Story summary

Kaiser Permanente has welcomed Dr. Daniel Yang as its new vice president of artificial intelligence, tasked with harnessing AI to tackle pressing healthcare challenges safely. In tandem, the FDA is set to unveil guidelines for managing AI-enabled medical devices, focusing on ensuring safety, efficacy, and addressing bias—paving the way for a more secure healthcare future.

1 of 1

Story summary

Kaiser Permanente has welcomed Dr. Daniel Yang as its new vice president of artificial intelligence, tasked with harnessing AI to tackle pressing healthcare challenges safely. In tandem, the FDA is set to unveil guidelines for managing AI-enabled medical devices, focusing on ensuring safety, efficacy, and addressing bias—paving the way for a more secure healthcare future.